1244 — 3D Medicines Cashflow Statement
0.000.00%
Last trade - 00:00- HK$957.84m
- HK$228.91m
- CNY445.65m
Annual cashflow statement for 3D Medicines, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | |
| Standards: | IFRS | IFRS | — | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -635 | -1,462 | -1,052 | -562 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 332 | 1,112 | 759 | 282 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 21.8 | -39.9 | -7.35 | 111 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Cash from Operating Activities | -278 | -377 | -279 | -144 | — |
| Capital Expenditures | -11.1 | -44.9 | -54 | -6.32 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -9.33 | -54 | -188 | -181 | — |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -20.5 | -98.9 | -242 | -188 | — |
| Financing Cash Flow Items | -18.5 | 309 | -24.2 | 11.5 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 607 | 840 | 408 | 305 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 302 | 360 | -77.6 | -30.3 | — |